Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction

American Journal of Cardiology

Volumn 110, Issue 1, 2012, Pages 83-87

  Bhat, Pradeep K ^a   Ashwath, Mahi L ^a   Rosenbaum, David S ^a   Costantini, Ottorino ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOMYOPATHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK;

AGED; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84862284103     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.054     Document Type: Article

References (26)

1. T.B. Levine, A.B. Levine, J. Bolenbaugh, R.J. Stomel Impact of left ventricular size on pharmacologic reverse remodeling in heart failure Clin Cardiol 23 2000 355 358
2. E. Kotlyar, C.S. Hayward, A.M. Keogh, M. Feneley, P.S. MacDonald The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter Heart 90 2004 800 801
3. F. Waagstein, M.R. Bristow, K. Swedberg, F. Camerini, M.B. Fowler, M.A. Silver, E.M. Gilbert, M.R. Johnson, F.G. Goss, A. Hjalmarson Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group Lancet 342 1993 1441 1446
4. S.L. Olsen, E.M. Gilbert, D.G. Renlund, D.O. Taylor, F.D. Yanowitz, M.R. Bristow Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study J Am Coll Cardiol 25 1995 1225 1231
5. S. Reiken, X.H. Wehrens, J.A. Vest, A. Barbone, S. Klotz, D. Mancini, D. Burkhoff, A.R. Marks Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure Circulation 107 2003 2459 2466
6. M.A. Pfeffer, E. Braunwald, L.A. MoyeMoyé, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, M. Klein, G.A. Lamas, M. Packer, J. Rouleau, J. Rouleau, J. Rutherfor, J.H. Wertheimer, C.M. Hawkins Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial The SAVE Investigators N Engl J Med 327 1992 669 677
7. H. Peng, O.A. Carretero, N. Vuljaj, T.D. Liao, A. Motivala, E.L. Peterson, N.E. Rhaleb Angiotensin-converting enzyme inhibitors: a new mechanism of action Circulation 112 2005 2436 2445
8. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
9. W.A. Zoghbi, M. Enriquez-Sarano, E. Foster, P.A. Grayburn, C.D. Kraft, R.A. Levine, P. Nihoyannopoulos, C.M. Otto, M.A. Quinones, H. Rakowski, W.J. Stewart, A. Waggoner, N.J. Weissman American Society of Echocardiography Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
10. Decision memo for implantable defibrillators (CAG-00157R3) http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx? NCAId=148%26ver=16%26NcaName=Implantable+Defibrillators+%26x28;3rd+Recon%26x29; %26bc=BEAAAAAAEAAA%26 Accessed November 27, 2011
11. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, K.P. Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, W.E. Sanders, A. Schaechter, J.H. Levine Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
12. D. Bänsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns, K. Seidl, M. Block, F. Gietzen, J. Berger, K.H. Kuck Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105 2002 1453 1458
13. S. Hein, S. Kostin, A. Heling, Y. Maeno, J. Schaper The role of the cytoskeleton in heart failure Cardiovasc Res 45 2000 273 278
14. S. Kostin, S. Hein, E. Arnon, D. Scholz, J. Schaper The cytoskeleton and related proteins in the human failing heart Heart Fail Rev 5 2000 271 280
15. J. Narula, N. Haider, E. Arbustini, Y. Chandrashekhar Mechanisms of disease: apoptosis in heart failure - seeing hope in death Nat Clin Pract Cardiovasc Med 3 2006 681 688
16. S.A. Strickberger, J.D. Hummel, T.G. Bartlett, H.I. Frumin, C.D. Schuger, S.L. Beau, C. Bitar, F. Morady AMIOVIRT Investigators Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT J Am Coll Cardiol 41 2003 1707 1712
17. A.S. Desai, J.C. Fang, W.H. Maisel, K.L. Baughman Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879
18. G.W. Woo, S. Petersen-Stejskal, J.W. Johnson, J.B. Conti, J.A. Aranda Jr, A.B. Curtis Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study J Interv Card Electrophysiol 12 2005 107 113
19. A. Lilli, G. Ricciardi, M.C. Porciani, A.P. Perini, P. Pieragnoli, N. Musilli, A. Colella, S. Del Pace, A. Michelucci, F. Turreni, M. Sassara, A. Achilli, S.S. Barold, L.L. Padeletti Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling Pacing Clin Electrophysiol 30 2007 1349 1355
20. S. Guerra, A. Leri, X. Wang, N. Finato, C. Di Loreto, C.A. Beltrami, J. Kajstura, P. Anversa Myocyte death in the failing human heart is gender dependent Circ Res 85 1999 856 866
21. G. Olivetti, G. Giordano, D. Corradi, M. Melissari, C. Lagrasta, S.R. Gambert, P. Anversa Gender differences and aging: effects on the human heart J Am Coll Cardiol 26 1995 1068 1079
22. B.K. Fornwalt, W.W. Sprague, P. BeDdell, J.D. Suever, B. Gerritse, J.D. Merlino, D.A. Fyfe, A.R. León, J.N. Oshinski Agreement is poor among current criteria used to define response to cardiac resynchronization therapy Circulation 121 2010 1985 1991
23. J.J. Bax, T.H. Marwick, S.G. Molhoek, G.B. Bleeker, L. van Erven, E. Boersma, P. Steendijk, E.E. van der Wall, M.J. Schalij Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation Am J Cardiol 92 2003 1238 1240
24. G.B. Bleeker, J.J. Bax, J.W.H. Fung, E.E. van der Wall, Q. Zhang, M.J. Schalij, J.Y.S. Chan, C.M. Yu Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy Am J Cardiol 97 2006 260 263
25. J.A. White, R. Yee, X.P. Yuan, A. Krahn, A. Skanes, M. Parker, G. Klein, M. Drangova Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony J Am Coll Cardiol 48 2006 1953 1960
26. E.G. Caiani, C. Corsi, J. Zamorano, L. Sugeng, P. MacEneaney, L. Weinert, R. Battani, J.L. Gutiérrez-Chico, R. Koch, L. Perez de Isla, V. Mor-Avi, R.M. Lang, R.M. Lang Improved semiautomated quantification of left ventricular volumes and ejection fraction using 3-dimensional echocardiography with a full matrix-array transducer: comparison with magnetic resonance imaging J Am Soc Echocardiogr 18 2005 779 788